Transcriptomics

Dataset Information

0

LYL1 facilitates AETFC assembly and gene activation by recruiting CARM1 in t(8;21) AML [RNA-seq]


ABSTRACT: Transcription factors (TFs) play critical roles in hematopoiesis, and their aberrant expression can lead to various types of leukemia. The t(8;21) leukemogenic fusion protein AML1-ETO (AE) is the most common fusion protein in acute myeloid leukemia and can enhance hematopoietic stem cell renewal while blocking differentiation. A key question in understanding AE-mediated leukemia is what determines the choice of AE to activate self-renewal genes or repress differentiation genes. Toward the resolution of this problem, we earlier showed that AE resides in the stable AETFC complex and that its components co-localize on up- or down-regulated target genes and are essential for leukemogenesis. In the current study, using biochemical and genomic approaches, we show that AE-containing complexes are heterogeneous, and that assembly of the larger AETFC (containing AE, HEB, E2A, LYL1, LMO2 and LDB2) requires LYL1. Furthermore, we provide strong evidence that the LYL1-containing AETFC preferentially binds to active enhancers and promotes AE-dependent gene activation. Moreover, we show that coactivator CARM1 interacts with AETFC and facilitates gene activation by AETFC. Collectively, this study describes a novel role of oncoprotein LYL1 in AETFC assembly and gene activation by recruiting CARM1 to chromatin for AML cell survival.

ORGANISM(S): Homo sapiens

PROVIDER: GSE207233 | GEO | 2022/11/10

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2022-11-10 | GSE207232 | GEO
2019-02-19 | GSE114642 | GEO
2019-03-04 | GSE121641 | GEO
2013-06-20 | E-GEOD-43834 | biostudies-arrayexpress
| PRJNA472044 | ENA
2018-08-13 | GSE103789 | GEO
2022-01-12 | PXD011251 | Pride
2018-12-14 | GSE114644 | GEO
2020-12-21 | GSE125025 | GEO
2019-09-02 | GSE122062 | GEO